Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (1675)	11/30/1999 10:29:00 AM
From: pz	Respond to of 5582

Hank, You'd be dangerous if you had a clue..... Paul

To: Hank who wrote (1675)	11/30/1999 10:50:00 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

<Sounds perfect for a company who's entire existence is based on products built up from hype and innuendo.> It's continual idiotic statements like this from you that eliminate any hope of your garnering credibility from anyone. If you want to be heard, then stop posting BS. Statements such as this one only hurt your cause. <Maybe you should start posting your estimates for next year too!> I already did. My estimate for FY 00 of $2.05 per share is based on conservative estimates for the gum business and Zicam. Like any analyst, I reserve the right to change my estimate as the revenue stream and costs become clearer. I will be more likely to increase than lower my estimate for Zicam sales next year due to demand being higher than expected in the US and abroad. There's no doubt in my mind that the company's profit next year will at least justify a stock price of $50 based on a PE of 25. Message 11832753 I lowered my estimate for Q4 to 18 cents per share from my previously published 27 cents per share because sales of Zicam are being limited by short term production issues. I also have a more conservative estimate for gum sales that are flat with Q3. There is more demand for Zicam than the company can meet right now, but this is only a short term problem as they ramp up production to meet the demand.